Latest News about Narcolepsy
Recent news which mentions Narcolepsy
Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ
January 09, 2025
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
October 06, 2021
From Benzinga
Needham Initiates Coverage With Buy For This Narcolepsy Player
September 23, 2021
From Benzinga
Canada Approves Jazz Pharma's Excessive Daytime Sleepiness Med
August 31, 2021
Tickers
JAZZ
From Benzinga
From Benzinga
NLS Pharma Stock Gains As Its Narcolepsy Candidate To Enter Mid-Stage Study Next Month
July 15, 2021
Tickers
NLSP
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>